Perspective Therapeutics, Inc.
CATX· NYSE
CATXPerspective Therapeutics, Inc.
Filed Sep 14, 2015 · 10-K · 76 days after period end · 0001144204-15-054865
| Metric | Q4 2015 | Q4 2014 | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.34M | $949.52K | $1.24M | $1.31M |
| Net Income | -$1.03M | -$1.68M | -$993.56K | -$1.21M |
| EPS Diluted | -$0.02 | -$0.04 | — | — |
Perspective Therapeutics, Inc. · CIK 728387 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Jun 30, 2015 · filed Sep 14, 2015 · 76 d after period end
